Cited 0 times in
Telisotuzumab vedotin (Teliso-V) in combination with osimertinib in patients with advanced EGFR-mutated, c-met overexpressing, non-small cell lung cancer (NSCLC): Safety and efficacy results from phase Ib study
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T01:14:11Z | - |
dc.date.available | 2023-06-02T01:14:11Z | - |
dc.date.issued | 2022-11 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194753 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Telisotuzumab vedotin (Teliso-V) in combination with osimertinib in patients with advanced EGFR-mutated, c-met overexpressing, non-small cell lung cancer (NSCLC): Safety and efficacy results from phase Ib study | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | H. Horinouchi | - |
dc.contributor.googleauthor | J.W. Goldman | - |
dc.contributor.googleauthor | B.C. Cho | - |
dc.contributor.googleauthor | P. Tomasini | - |
dc.contributor.googleauthor | M. Dunbar | - |
dc.contributor.googleauthor | D. Hoffman | - |
dc.contributor.googleauthor | A. Parikh | - |
dc.contributor.googleauthor | V. Blot | - |
dc.contributor.googleauthor | D.R. Camidge | - |
dc.identifier.doi | 10.1016/j.annonc.2022.10.424 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422046154 | - |
dc.citation.volume | 33 | - |
dc.citation.number | Suppl 9 | - |
dc.citation.startPage | S1592 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl 9) : S1592, 2022-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.